Literature DB >> 25772938

MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.

Yong Q Cheng1,2, Jun P Ren1, Juan Zhao1, Jia M Wang1,3, Yun Zhou1,4, Guang Y Li1, Jonathan P Moorman1,5, Zhi Q Yao1,5.   

Abstract

Host immune responses must be tightly regulated by an intricate balance between positive and negative signals while fighting pathogens; persistent pathogens may usurp these regulatory mechanisms to dampen host immunity to facilitate survival in vivo. Here we report that Tim-3, a negative signalling molecule expressed on monocytes and T cells, is up-regulated on natural killer (NK) cells in individuals chronically infected with hepatitis C virus (HCV). Additionally, the transcription factor T-bet was also found to be up-regulated and associated with Tim-3 expression in NK cells during chronic HCV infection. MicroRNA-155 (miR-155), an miRNA that inhibits signalling proteins involved in immune responses, was down-regulated in NK cells by HCV infection. This Tim-3/T-bet over-expression and miR-155 inhibition were recapitulated in vitro by incubating primary NK cells or NK92 cell line with Huh-7 hepatocytes expressing HCV. Reconstitution of miR-155 in NK cells from HCV-infected patients led to a decrease in T-bet/Tim-3 expression and an increase in interferon-γ production. Blocking Tim-3 signalling also enhanced interferon-γ production in NK cells by improving signal transducer and activator of transcription-5 phosphorylation. These data indicate that HCV-induced, miR-155-regulated Tim-3 expression regulates NK cell function, suggesting a novel mechanism for balancing immune clearance and immune injury during chronic viral infection.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  T-cell immunoglobulin and mucin domain protein-3; hepatitis C virus; interferon-γ; microRNA-155; natural killer cells; signal transducer and activator of transcription-5

Mesh:

Substances:

Year:  2015        PMID: 25772938      PMCID: PMC4515129          DOI: 10.1111/imm.12463

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  50 in total

1.  miR-155 regulates IFN-γ production in natural killer cells.

Authors:  Rossana Trotta; Li Chen; David Ciarlariello; Srirama Josyula; Charlene Mao; Stefan Costinean; Lianbo Yu; Jonathan P Butchar; Susheela Tridandapani; Carlo M Croce; Michael A Caligiuri
Journal:  Blood       Date:  2012-02-29       Impact factor: 22.113

2.  Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1.

Authors:  Pin Wang; Jin Hou; Li Lin; Chunmei Wang; Xingguang Liu; Dong Li; Feng Ma; Zhugang Wang; Xuetao Cao
Journal:  J Immunol       Date:  2010-10-11       Impact factor: 5.422

Review 3.  Novel therapies for hepatitis C - one pill fits all?

Authors:  Michael P Manns; Thomas von Hahn
Journal:  Nat Rev Drug Discov       Date:  2013-06-28       Impact factor: 84.694

4.  Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function.

Authors:  Jian-Xin Lin; Peng Li; Delong Liu; Hyun Tak Jin; Jianping He; Mohammed Ata Ur Rasheed; Yrina Rochman; Lu Wang; Kairong Cui; Chengyu Liu; Brian L Kelsall; Rafi Ahmed; Warren J Leonard
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

5.  Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.

Authors:  Jeffrey W Leong; Julie M Chase; Rizwan Romee; Stephanie E Schneider; Ryan P Sullivan; Megan A Cooper; Todd A Fehniger
Journal:  Biol Blood Marrow Transplant       Date:  2014-01-13       Impact factor: 5.742

Review 6.  Hepatitis C virus and microRNAs: miRed in a host of possibilities.

Authors:  Ragunath Singaravelu; Rodney S Russell; D Lorne Tyrrell; John Paul Pezacki
Journal:  Curr Opin Virol       Date:  2014-04-12       Impact factor: 7.090

Review 7.  MicroRNA function in NK-cell biology.

Authors:  Aimee M Beaulieu; Natalie A Bezman; Jang Eun Lee; Mehrdad Matloubian; Joseph C Sun; Lewis L Lanier
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

8.  Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.

Authors:  Lucy Golden-Mason; Brent E Palmer; Nasim Kassam; Lisa Townshend-Bulson; Stephen Livingston; Brian J McMahon; Nicole Castelblanco; Vijay Kuchroo; David R Gretch; Hugo R Rosen
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

9.  Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.

Authors:  Ying Zhang; Cheng J Ma; Jia M Wang; Xiao J Ji; Xiao Y Wu; Zhan S Jia; Jonathan P Moorman; Zhi Q Yao
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

10.  Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection.

Authors:  Shashi Bala; Yaphet Tilahun; Odette Taha; Hawau Alao; Karen Kodys; Donna Catalano; Gyongyi Szabo
Journal:  J Transl Med       Date:  2012-07-30       Impact factor: 5.531

View more
  29 in total

Review 1.  Role of Tim-3 in hepatitis B virus infection: An overview.

Authors:  Yuan Liu; Li-Fen Gao; Xiao-Hong Liang; Chun-Hong Ma
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

2.  Expression of microRNA-155 in inflammatory cells modulates liver injury.

Authors:  Delia Blaya; Beatriz Aguilar-Bravo; Fengjie Hao; Silvia Casacuberta-Serra; Mar Coll; Luis Perea; Júlia Vallverdú; Isabel Graupera; Elisa Pose; Laura Llovet; Jordi Barquinero; Francisco Javier Cubero; Juan Caballería; Pere Ginès; Pau Sancho-Bru
Journal:  Hepatology       Date:  2018-05-02       Impact factor: 17.425

3.  The relevance of Tim-3 polymorphisms and F protein to the outcomes of HCV infection.

Authors:  J P Pei; L F Jiang; X W Ji; W Xiao; X Z Deng; Z X Zhou; D Y Zhu; W L Ding; J H Zhang; C J Wang; K Jing
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-26       Impact factor: 3.267

4.  T-bet-mediated Tim-3 expression dampens monocyte function during chronic hepatitis C virus infection.

Authors:  Wenjing Yi; Peixin Zhang; Yan Liang; Yun Zhou; Huanjun Shen; Chao Fan; Jonathan P Moorman; Zhi Q Yao; Zhansheng Jia; Ying Zhang
Journal:  Immunology       Date:  2016-12-07       Impact factor: 7.397

5.  Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms.

Authors:  Bing Sun; Linda Abadjian; Alexander Monto; Heather Freasier; Lynn Pulliam
Journal:  J Infect Dis       Date:  2020-07-06       Impact factor: 5.226

Review 6.  Immunopathogenesis of Hepatitis C Virus Infection.

Authors:  David E Kaplan
Journal:  Gastroenterol Clin North Am       Date:  2015-08-13       Impact factor: 3.806

7.  Downregulated Tim-3 expression is responsible for the incidence and development of colorectal cancer.

Authors:  Ping Zhang; Yan Wang; Xue-Rong Liu; Shi-Ru Hong; Jian Yao
Journal:  Oncol Lett       Date:  2018-05-11       Impact factor: 2.967

8.  MicroRNA155 Plays a Critical Role in the Pathogenesis of Cutaneous Leishmania major Infection by Promoting a Th2 Response and Attenuating Dendritic Cell Activity.

Authors:  Sanjay Varikuti; Chaitenya Verma; Gayathri Natarajan; Steve Oghumu; Abhay R Satoskar
Journal:  Am J Pathol       Date:  2021-02-02       Impact factor: 4.307

9.  Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection.

Authors:  Jun P Ren; Lin Wang; Juan Zhao; Ling Wang; Shun B Ning; Mohamed El Gazzar; Jonathan P Moorman; Zhi Q Yao
Journal:  Immunology       Date:  2016-11-11       Impact factor: 7.397

Review 10.  Detection of Immune Checkpoint Receptors - A Current Challenge in Clinical Flow Cytometry.

Authors:  Benjamin Shibru; Katharina Fey; Stephan Fricke; André-René Blaudszun; Friederike Fürst; Max Weise; Sabine Seiffert; Maria Katharina Weyh; Ulrike Köhl; Ulrich Sack; Andreas Boldt
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.